Todos Medical Supports Long COVID Awareness Day
15. März 2023 14:27 ET
|
Todos Medical Ltd.
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions...
Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
16. November 2022 07:30 ET
|
Todos Medical Ltd.
Affy Services, Smart Automated Retail Network Parent Company, to Also Represent Todos for Traditional Shelf Space to Its 20,000+ US-based Retail Grocery Store Locations NEW YORK, NY, and TEL AVIV,...
Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022
14. November 2022 18:26 ET
|
Todos Medical Ltd.
NEW YORK, NY, AND TEL AVIV, ISRAEL, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Enters Into $50M Contract to Supply Tollovid™ and CBD Products to Retail Distributor Company Nerd Hemp
22. September 2022 16:02 ET
|
Todos Medical Ltd.
5500 Automated Retail Machines to be Rolled out in Q4/22 and Q1/23 $11.5M in Q4/22 Revenue Expected From This Agreement NEW YORK, NY and TEL AVIV, ISRAEL, Sept. 22, 2022 (GLOBE NEWSWIRE) -- via...
Todos Medical Announces NFL Hall of Famer Michael Irvin as Tollovid™ Sports Ambassador for #TolloUp Campaign
16. September 2022 07:30 ET
|
Todos Medical Ltd.
NEW YORK, NY and Tel Aviv, ISRAEL, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
25. August 2022 07:30 ET
|
Todos Medical Ltd.
Patient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune Long COVID Panel and Provista research-use-only MonkeyPox assays to assess effect of TPoxx...
Todos Medical Reports Second Quarter 2022 Financial Results and Business Update Conference Call on Tuesday, August 23 at 8:30am ET
22. August 2022 21:41 ET
|
Todos Medical Ltd.
Preparations for Tollovir™ Phase 2 Trial Extension to Support EUA Filing Now Complete Preparations for Tollovid™ Phase 2 Trial in Long COVID Now Complete Launch of New Suite of PCR Tests at...
Todos Medical Announces Commercialization of Lesion and Saliva-Based MonkeyPox PCR Testing
22. August 2022 06:30 ET
|
Todos Medical Ltd.
Provista begins validation preparations for blood-based IgM/IgG MonkeyPox LDTCompany to release its Q2/2022 10Q quarterly report at 4:05 pm ET this afternoonCompany to host business update conference...
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
28. Juli 2022 07:30 ET
|
Todos Medical Ltd.
NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Completes Validation of 27 Pathogen UTI PCR Panel at Its CLIA/CAP Laboratory Provista Diagnostics
13. Juni 2022 07:45 ET
|
Todos Medical Ltd.
NEW YORK, NY and TEL AVIV, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...